mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |